OXBOxford BiomedicaOXB info
$4.51info1.04%24h
Global rank12251
Market cap$436.38M
Change 7d-4.74%
YTD Performance59.21%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Oxford Biomedica (OXB) Stock Overview

    Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and development of new gene therapeutic product candidates. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, and adenoviral vectors. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom.

    OXB Stock Information

    Symbol
    OXB
    Address
    Windrush CourtOxford, OX4 6LTUnited Kingdom
    Founded
    -
    Trading hours
    8:00 AM - 4:30 PM GMT
    Website
    https://www.oxb.com
    Country
    🇬🇧 United Kingdom
    Phone Number
    44 1865 783 000

    Oxford Biomedica (OXB) Price Chart

    -
    Value:-

    Oxford Biomedica Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $4.51
    N/A
    Market Cap
    $436.38M
    N/A
    Shares Outstanding
    96.80M
    N/A
    Employees
    891.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org